Telephone
61.3.9420.8235
Address
Level 1 510 Church Street Cremorne, Victoria (VIC) 3121
Description
Monash IVF Group Ltd. engages in the field of fertility services. It operates through the Monash IVF Group Australia and Monash IVF Group International segments. The Monash IVF Group Australia segment provides assisted reproductive services, ultrasound, and other related services. The Monash IVF Group International segment focuses on reproductive services in Southeast Asia. The company was founded on April 30, 2014 and is headquartered in Cremorne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.93 - 1.35
Trade Value (12mth)
AU$237,043.00
1 week
2.69%
1 month
3.49%
YTD
43.55%
1 year
36.22%
All time high
2.38151
EPS 3 yr Growth
23.100%
EBITDA Margin
23.60%
Operating Cashflow
$38m
Free Cash Flow Return
10.80%
ROIC
6.20%
Interest Coverage
15.20
Quick Ratio
0.50
Shares on Issue (Fully Dilluted)
392m
HALO Sector
Healthcare
Next Company Report Date
26-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.32
Date | Announcements |
---|---|
31 May 23 |
Notification of Release of Restricted Shares held in Escrow
×
Notification of Release of Restricted Shares held in Escrow |
30 September 22 |
ART Associates QLD completion
×
ART Associates QLD completion |
30 April 15 |
Corporate Presentation April 2015
×
Corporate Presentation April 2015 |
29 May 23 |
PIVET Medical Centre completion
×
PIVET Medical Centre completion |
28 October 14 |
Annual General Meeting Chairman and CEO presentation.
×
Annual General Meeting Chairman and CEO presentation. |
28 November 23 |
2023 AGM - Chairman's Address
×
2023 AGM - Chairman's Address |
28 November 23 |
2023 AGM - Presentation
×
2023 AGM - Presentation |
28 November 23 |
MVF 2023 AGM Results
×
MVF 2023 AGM Results |
28 November 19 |
AGM Presentation
×
AGM Presentation |
28 August 15 |
Monash IVF Group Investor Presentation
×
Monash IVF Group Investor Presentation |
28 August 14 |
Monash IVF 2014 Financial results presentation
×
Monash IVF 2014 Financial results presentation |
27 September 23 |
Notification of Release of Restricted Shares Held in Escrow
×
Notification of Release of Restricted Shares Held in Escrow |
27 October 23 |
FY2023 Annual Report to Shareholders
×
FY2023 Annual Report to Shareholders |
27 October 23 |
Notice of 2023 Annual General Meeting / Proxy Form
×
Notice of 2023 Annual General Meeting / Proxy Form |
27 October 23 |
MVF 2023 Sustainability Report
×
MVF 2023 Sustainability Report |
27 March 23 |
Change in substantial holding
×
Change in substantial holding |
27 August 18 |
Financial Results Presentation FY2018
×
Financial Results Presentation FY2018 |
27 April 20 |
Investor Presentation
×
Investor Presentation |
26 September 14 |
Annual Report to shareholders
×
Annual Report to shareholders |
26 September 14 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
26 November 20 |
2020 AGM Presentation
×
2020 AGM Presentation |
26 November 15 |
2015 AGM Presentation
×
2015 AGM Presentation |
26 February 18 |
Monash IVF Group 1H18 Results Presentation
×
Monash IVF Group 1H18 Results Presentation |
26 February 16 |
Monash IVF Group 1H16 Results Presentation
×
Monash IVF Group 1H16 Results Presentation |
26 August 22 |
MVF FY22 Appendix 4E and Financial Report
×
MVF FY22 Appendix 4E and Financial Report |
26 August 22 |
Appendix 4G
×
Appendix 4G |
26 August 22 |
MVF sets foundation for long-term growth
×
MVF sets foundation for long-term growth |
26 August 22 |
MVF FY22 Results Presentation
×
MVF FY22 Results Presentation |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.